Showing results (61-70 of 122) with videos related to
Sort By:
Pageof 13
International Journal of Cardiology|January 16, 2009
Survival after stroke--the impact of CHADS2 score and atrial fibrillationKarin M Henriksson, Bahman Farahmand, Saga Johansson, et al.Pharmacoepidemiology and Drug Safety|April 22, 2008
The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary careLuis Alberto García-Rodríguez, Elvira Luján Massó-González, Mari-Ann Wallander, et al.International Journal of Cardiology|July 16, 2008
Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosisAna Ruigómez, Saga Johansson, Mari-Ann Wallander, et al.Family Practice|August 31, 2007
Dyspepsia in general practice: incidence, risk factors, comorbidity and mortalityMari-Ann Wallander, Saga Johansson, Ana Ruigómez, et al.Drug Safety|February 18, 2010
Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenariosSaga Johansson, Mari-Ann Wallander, Francisco J de Abajo, et al.The American Journal of Gastroenterology|December 13, 2006
A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome--women are more seriously affected than menAshild Faresjö, Ewa Grodzinsky, Saga Johansson, et al.BMC Public Health|April 25, 2006
The prognosis for individuals on disability retirement. An 18-year mortality follow-up study of 6887 men and women sampled from the general populationThorne Wallman, Hans Wedel, Saga Johansson, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 15, 2014
Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleedingMaría E Sáez, Antonio González-Pérez, Saga Johansson, et al.Journal of Vascular Surgery|May 23, 2016
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularizationBirgitta Sigvant, Björn Kragsterman, Mårten Falkenberg, et al.Pharmacoepidemiology and Drug Safety|December 7, 2016
Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleedingAntonio González-Pérez, María Eugenia Sáez, Saga Johansson, et al.Pageof 13